ScholarIQanswers from OpenAlex

Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead

PaperCitations, authors & open-access status

Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead have?

ScholarIQcitation count

Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead has 205 citations in the OpenAlex counts ScholarIQ stores.

When was Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead published?

ScholarIQyear

Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead has 2021 year in the ScholarIQ index.

What is the open-access status of Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead?

ScholarIQoa status

Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead has gold oa status in the ScholarIQ index.

What is the DOI of Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead?

ScholarIQdoi

The DOI for Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead is on the source record.

What is the PMID of Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead?

ScholarIQpmid

The PMID for Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead is on the source record.

What is the OpenAlex record for Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead?

ScholarIQopenalex

The OpenAlex for Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial